Paeds SAQs · allergy-and-immunology
Food allergy management and prevention — formative SAQs
Two formative short-answer questions on managing a confirmed food-allergy reaction and on early-allergen-introduction prevention in a high-risk infant.
On this page & tools
Target exams
SAQ 1 — Manage the reaction (10 marks)
A six-year-old with known peanut allergy and mild asthma develops lip swelling, widespread urticaria, wheeze and drowsiness within five minutes of eating a biscuit at a party. A carer has a 0.15 mg adrenaline autoinjector. [14] [6]
Questions
- Outline the immediate management of this reaction and the rationale for each step. (4 marks) [14]
- State the weight-banded adrenaline dosing approach and when to repeat it. (2 marks) [14]
- Describe the disposition and observation plan, including the biphasic risk. (2 marks) [14] [6]
- Outline the written action plan and equipment the family should leave with. (2 marks) [6] [14]
Model answer
Immediate management (4). Call for help. IM adrenaline into the anterolateral thigh as the first drug — do not wait for antihistamines or IV access. Lie flat with legs elevated if shocked; high-flow oxygen; IV fluids for shock; bronchodilator adjunctive for wheeze. Reassess ABCDE continuously. [14]
Dosing and repeat (2). Roughly 0.01 mg/kg of 1:1000 (1 mg/mL) IM; autoinjector doses 0.15 mg for smaller children (under ~20 kg) and 0.30 mg for larger (~20 kg and over). Repeat after 5 minutes if no response. [14]
Disposition (2). Observe for biphasic reaction — at least 6 hours for moderate reactions. Admit this child because of co-existing asthma and the severe initial reaction, and because more than one adrenaline dose may be needed. [14] [6]
Action plan and equipment (2). Personalised written anaphylaxis action plan (ASCIA/BSACI/FARE) with photo, allergen, dose and stepwise response; two adrenaline autoinjectors by weight; medical-alert identification; school/childcare plan and staff training. [6] [14]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References7Show ledgerHide ledger
- [1]Du Toit G Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med, 2015.PMID 25705822
- [2]Du Toit G Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med, 2016.PMID 26942922
- [4]Togias A Addendum guidelines for the prevention of peanut allergy in the United States: Report of the NIAID-sponsored expert panel. J Allergy Clin Immunol, 2017.PMID 28065278
- [6]Sicherer SH Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol, 2018.PMID 29157945
- [9]Natsume O Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT). Lancet, 2017.PMID 27939035
- [13]Halken S EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update). Pediatr Allergy Immunol, 2021.PMID 33710678
- [14]Simons FE World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol, 2013.PMID 24008815